Pro se Plaintiff Joseph Favors brings a products liability claim related to the sale and marketing of Zantac, generically known as ranitidine. This case is related to the multidistrict litigation (the “MDL”) In re Zantac (Ranitidine), 20-MD-2924. As part of the MDL, the Court previously entered an Omnibus Order granting the pharmaceutical Defendants’ Daubert Motions on general causation and their Motion for Summary Judgment. 20-MD-2924, DE 6120. The Court subsequently ordered plaintiffs to proceed through a show cause process as to why the Court’s Omnibus Order did not apply to their case. 20-MD-2924, DE 6271 (“Pretrial Order 81”). As part of that process, plaintiffs were first required to file a notice of each claim they sought to pursue and certify their intent to provide general causation expert reports in support of those claims. Id. Plaintiff, here, has provided such a notice. Thus, his next step is to serve a general causation expert report on Defendant and file a notice listing all experts for whom Plaintiff has provided a report. Per the Court’s most recent order, Plaintiff has until November 4, 2025, to do so. 21-cv-81180, DE 27. Upon Plaintiff’s motion, his case was referred to the Volunteer Attorney Program for voluntary, pro bono assistance with this requirement. If interested, please email FLSD_ProBono@flsd.uscourts.gov